Patents/Assignees

Dyne Therapeutics, Inc.

47 patents in portfolio

US12144867utility2024
Muscle Targeting Complexes and Uses Thereof for Treating Dystrophinopathies
0 cites
US12144868utility2024
Muscle Targeting Complexes and Uses Thereof for Treating Dystrophinopathies
0 cites
US12128109utility2024
Muscle Targeting Complexes and Formulations for Treating Dystrophinopathies
0 cites
US12102687utility2024
Muscle Targeting Complexes and Uses Thereof for Treating Myotonic Dystrophy
0 cites
US12097263utility2024
Muscle Targeting Complexes and Uses Thereof for Treating Myotonic Dystrophy
0 cites
US12018087utility2024
Muscle-targeting Complexes Comprising an Anti-transferrin Receptor Antibody Linked to an Oligonucleotide and Methods of Delivering Oligonucleotide to a Subject
0 cites
US12012460utility2024
Muscle-targeting Complexes Comprising an Anti-transferrin Receptor Antibody Linked to an Oligonucleotide
0 cites
US12005124utility2024
Muscle Targeting Complexes and Uses Thereof for Treating Dystrophinopathies
0 cites
US11986537utility2024
Muscle Targeting Complexes and Uses Thereof for Treating Dystrophinopathies
0 cites
US11969475utility2024
Muscle Targeting Complexes and Uses Thereof for Treating Facioscapulohumeral Muscular Dystrophy
0 cites
US11931421utility2024
Muscle Targeting Complexes and Formulations for Treating Myotonic Dystrophy
0 cites
US11911484utility2024
Muscle Targeting Complexes and Uses Thereof for Treating Myotonic Dystrophy
0 cites
US11844843utility2023
Muscle Targeting Complexes and Uses Thereof for Treating Facioscapulohumeral Muscular Dystrophy
0 cites
US11839660utility2023
Anti-transferrin Receptor Antibody and Uses Thereof
0 cites
US11833217utility2023
Muscle Targeting Complexes and Uses Thereof for Treating Dystrophinopathies
0 cites
US11795233utility2023
Muscle-targeting Complex Comprising an Anti-transferrin Receptor Antibody Linked to an Oligonucleotide
0 cites
US11795234utility2023
Methods of Producing Muscle-targeting Complexes Comprising an Anti-transferrin Receptor Antibody Linked to an Oligonucleotide
0 cites
US11787869utility2023
Methods of Using Muscle Targeting Complexes to Deliver an Oligonucleotide to a Subject Having Facioscapulohumeral Muscular Dystrophy or a Disease Associated with Muscle Weakness
0 cites
US11771776utility2023
Muscle Targeting Complexes and Uses Thereof for Treating Dystrophinopathies
0 cites
US11759525utility2023
Muscle Targeting Complexes and Uses Thereof for Treating Facioscapulohumeral Muscular Dystrophy
0 cites

← PreviousPage 2 of 3Next →